• Gender Differences In Health-Care Related Expenditures For Patients With Arthritis In The United States

    May 1, 2013, 00:00

  • Assessing the impact of a medicaid prior authorization (PA) policy for duloxetine on antipsychotic use among patients with depression

    May 1, 2013, 00:00

  • Using A HA-CMC Barrier To Avoid Pelvic Or Abdominal Adhesion- Cost-Benefit Advantages In A Private Health Care Setting

    May 1, 2013, 00:00

  • Multicomponent Home-Based Environmental Interventions Are Effective In Reducing Morbidity Of Children With Asthma From Low Income Families

    May 1, 2013, 00:00

  • Time and motion study design- Handling variability and confounding of results

    May 1, 2013, 00:00

  • Achieving Formulary (Drug List) Access And Utilization Of Oncology Drugs In China

    May 1, 2013, 00:00

  • Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients- A retrospective cost analysis

    May 1, 2013, 00:00

  • Economic modeling in hiv for maraviroc in tretament-naive patients in the united states – Results from the aramis-mvc 2012 model

    May 1, 2013, 00:00

  • Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics

    May 1, 2013, 00:00

  • Quantification Of Benefits And Risks In Medical Imaging Testing- A Literature Review

    May 1, 2013, 00:00

  • Association between cardiovascular biomarkers levels and cigarette smoking among current smokers, past smokers and non smokers using nhanes 2007-2010

    May 1, 2013, 00:00

  • Validation and psychometric evaluation of a patient-reported assessment of disease burden- Evidence from a sample of adults with diabetes, depression, and rheumatoid arthritis

    May 1, 2013, 00:00

  • Determining the current state-of-play for variants of the ‘short form' health-related quality of life instrument in spinal cord injury- A systematic literature review

    May 1, 2013, 00:00

  • Treating urge incontinence in older adults- A quality adjusted life-year (QALY) bargain

    May 1, 2013, 00:00

  • Health-related quality of life (HRQOL) in colorectal cancer patients who finish their treatment in a tertiary hospital

    May 1, 2013, 00:00

  • Treatment Patterns Of Adalimumab And Infliximab In The Treatment Of Crohn's Disease Over A Three-Year Period- A Canadian Assessment

    May 1, 2013, 00:00

  • Psychometric performance of the nei VFQ-25- recommendations for a modified version of the 25-item national eye institute questionnaire (NEI VFQ-25) based on rasch analysis using clinical trials data across four retinal diseases

    May 1, 2013, 00:00

  • Optimizing real world data collection for comparative effectiveness and market access

    May 1, 2013, 00:00

  • Melanoma health care pathways in an italian population

    May 1, 2013, 00:00

  • Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-Naïve People With Type-2 Diabetes

    May 1, 2013, 00:00

  • Impact Of Oral Medication Adherence And Lab Testing On Five-Year Total Medical Costs In A Commercially Insured Diabetic Population

    May 1, 2013, 00:00

  • Racial And Ethnic Disparity In Smoking Cessation Medication Use Among Adult Smokers In The United States

    May 1, 2013, 00:00

  • Prediction of mortality in the presence of time-depended covariates- An application for health ecomonic projections

    May 1, 2013, 00:00

  • Pattern Of Prescribing- Information From Community Pharmacies In The Province Of Basrah, Iraq

    May 1, 2013, 00:00

  • The Cost And Productivity Consequences Of Non-Severe Hypoglycaemic Episodes (Nshe) In Patients Treated With Sulfonylurea Or Dpp4 Dual Combination Oral Therapy

    May 1, 2013, 00:00

  • The Cost And The Educational Impact Of Cochlear Implantation In Children Over A Four Year Period In France

    May 1, 2013, 00:00

  • Exploration of heterogeneity in distributed research network drug safety analyses

    May 1, 2013, 00:00

  • A Systematic Literature Review Of Methodologies Used To Assess Medication Adherence In Patients With Diabetes

    May 1, 2013, 00:00

  • Drivers Of Cost-Effectiveness In Type-2 Diabetes Mellitus

    May 1, 2013, 00:00

  • Dose relativity of sevelamer hydrochloride and lanthanum carbonate under real-world conditions- Implications for management of patients with end-stage renal disease and hyperphosphatemia

    May 1, 2013, 00:00

  • Generating distributions and data- evaluating online, freeware options for health economic models

    May 1, 2013, 00:00

  • Using the quality of health economic studies instrument to assess pharmacoeconomic studies evaluating recent food and drug administration drug approvals

    May 1, 2013, 00:00

  • Costs Of Chemotherapy In Hospital And Office-Based Settings- Policy Implications For Cancer Cost Control

    May 1, 2013, 00:00

  • Annual Mortality In A Large Prevalence-Based Sample Of United States Rheumatoid Arthritis Patients

    May 1, 2013, 00:00

  • Cost Analysis Of Antibiotics Utilization In Respiratory Tract Infection Using Prescribing Indicators

    May 1, 2013, 00:00

  • Health State Utilities Values For Post-Menopausal Women From The Women's Health Initiative Estrogen+Progestin Clincial Trial

    May 1, 2013, 00:00

  • Effect Of Ascorbic Acid On Blood Lead Levels Among School Going Adolescents In Karachi- A Cluster Randomized Trial

    May 1, 2013, 00:00

  • Using Phone Triage With Risk Stratification To Initiate Low Back Pain Care Within A Health Care System

    May 1, 2013, 00:00

  • Bayesian mixed treatment comparison (MTC)- A novel method to demonstrate equivalence and non-inferiority

    May 1, 2013, 00:00

  • An integrated analysis of relapses requiring intravenous steroid use and multiple sclerosis (MS)-related hospitalizations from the BG-12 (dimethyl fumarate) phase 3 define and confirm studies

    May 1, 2013, 00:00

  • National trends in psychotropic medications use among children with attention deficit hyperactivity disorder (ADHD) in the United States

    May 1, 2013, 00:00

  • Medication Use Survey Of Inpatients With Basic Medical Insurance From 2009 To 2010

    May 1, 2013, 00:00

  • Cost Of Outbreak Of Meningococcal Disease In A Colombian Caribbean City, 2012

    May 1, 2013, 00:00

  • Use Of Biologically Based Therapies (Bbts) And Assessment Of Health Related Quality Of Life (Hrqol) Among Malaysian Cancer Patients

    May 1, 2013, 00:00

  • Trend In Economic Burden Of Diabetes In Urban China From 2009 To 2011

    May 1, 2013, 00:00

  • A Qualitative Exploration Of Perceptions Towards Pharmaceutical Price War Among Community Pharmacies In The State Of Penang, Malaysia

    May 1, 2013, 00:00

  • Examination Of University Students' Intention To Utilize Emergency Contraception Using The Theory Of Planned Behavior

    May 1, 2013, 00:00

  • Burden Of Disease Of Osteoarthritis In Russia- Results From 2011 National Health And Wellness Survey (Nhws)

    May 1, 2013, 00:00

  • Identifying patient subpopulations in early development to substantiate value

    May 1, 2013, 00:00

  • Cost-Effectiveness And Cost-Utility Analyses Of Fixed-Dose Combination Of Naproxen And Esomeprazole Magnesium For Osteoarthritis Patients At Risk Of Developing Gastric Or Duodenal Ulcer

    May 1, 2013, 00:00

  • The effect of redesigned computerized drug-drug interaction alerts on medication errors and prescribing efficiency

    May 1, 2013, 00:00

  • Medication adherence for clozapine versus other second-generation antipsychotic drugs in patients with schizophrenia

    May 1, 2013, 00:00

  • Skeletal-Related Events And Mortality Among Seer-Medicare Patients With Metastatic Prostate Cancer- The Implications Of Measurement Approach

    May 1, 2013, 00:00

  • Cost Effectiveness Analysis Of Abiraterone Acetate As Treatment For Metastatic Castration Resistant Prostate Cancer After Failure Of Docetaxel Using Data From Real Life Treatment Praxis In Sweden

    May 1, 2013, 00:00

  • Antiretroviral Adherence Among Medicaid-Insured Hiv Patients Initiating Current Guideline-Preferred Antiretroviral Therapy Regimens

    May 1, 2013, 00:00

  • Hospitalization Resource Use and Costs Before and After TIA and Stroke- Results from a Population-Based Cohort Study (OXVASC)

    Mar 1, 2013, 00:00

  • Assessing the Determinants of the Potential for Cost-Effectiveness Over Time- The Empirical Case of COPD

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of a Novel SIAscopic Diagnostic Aid for the Management of Pigmented Skin Lesions in Primary Care- A Decision-Analytic Model

    Mar 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Early versus Late Total Hip Replacement in Italy

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of a Program to Eliminate Disparities in Pneumococcal Vaccination Rates in Elderly Minority Populations- An Exploratory Analysis

    Mar 1, 2013, 00:00

  • Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States

    Mar 1, 2013, 00:00

  • Economic Measurement of Medical Errors Using a Hospital Claims Database

    Mar 1, 2013, 00:00

  • Comparative Incidence and Health Care Costs of Medically Attended Adverse Effects among U.S. Medicaid HIV Patients on Atazanavir- or Darunavir-Based Antiretroviral Therapy

    Mar 1, 2013, 00:00

  • Table of Contents

    Mar 1, 2013, 00:00

  • Instructions for Authors

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer

    Mar 1, 2013, 00:00

  • Patient Preferences for Biologic Agents in Rheumatoid Arthritis- A Discrete-Choice Experiment

    Mar 1, 2013, 00:00

  • Cost-Effectiveness of Enhancing Adherence to Therapy with Blood Pressure–Lowering Drugs in the Setting of Primary Cardiovascular Prevention

    Mar 1, 2013, 00:00

  • Progression-Free Survival with Fulvestrant 500 mg and Alternative Endocrine Therapies as Second-Line Treatment for Advanced Breast Cancer- A Network Meta-Analysis with Parametric Survival Models

    Mar 1, 2013, 00:00

  • An Expert on Every Street Corner? Methods for Eliciting Distributions in Geographically Dispersed Opinion Pools

    Mar 1, 2013, 00:00

  • Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire Scores in Patients with Colorectal Cancer

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of Duloxetine in Chronic Low Back Pain- A US Private Payer Perspective

    Mar 1, 2013, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration- A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

    Mar 1, 2013, 00:00

  • Editorial Board

    Mar 1, 2013, 00:00

  • The Comparison of Trial Data–Based and Registry Data–Based Cost-Effectiveness of Infliximab Treatment for Rheumatoid Arthritis in Sweden Using a Modeling Approach

    Mar 1, 2013, 00:00

  • Copyright/Subscription

    Mar 1, 2013, 00:00

  • Response about Rank Reversal

    Mar 1, 2013, 00:00

  • The Cost-Effectiveness of the Levonorgestrel-Releasing Intrauterine System for the Treatment of Idiopathic Heavy Menstrual Bleeding in the United States

    Mar 1, 2013, 00:00

  • Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

    Mar 1, 2013, 00:00

  • Erratum

    Mar 1, 2013, 00:00

  • Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder

    Mar 1, 2013, 00:00

  • Improving the Quality of Papers Published in Pharmacoeconomics and Outcomes Research

    Mar 1, 2013, 00:00

  • Quality of Life in the First 6 Weeks Following Laparoscopic and Open Colorectal Surgery

    Mar 1, 2013, 00:00

  • Evaluating the Impact of Unmeasured Confounding with Internal Validation Data- An Example Cost Evaluation in Type 2 Diabetes

    Mar 1, 2013, 00:00

  • Evidence Synthesis Assumes Additivity on the Scale of Measurement- Response to “Rank Reversal in Indirect Comparisons” by Norton et al.

    Mar 1, 2013, 00:00

  • Understanding the Costs of Care for Cystic Fibrosis- An Analysis by Age and Health State

    Mar 1, 2013, 00:00

  • Need for Speed- An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information

    Mar 1, 2013, 00:00

  • Table of Contents

    Jan 1, 2013, 00:00

  • Consumer Preferences for Health and Nonhealth Outcomes of Health Promotion- Results from a Discrete Choice Experiment

    Jan 1, 2013, 00:00

  • Responsiveness of the EQ-5D Health-Related Quality-of-Life Instrument in Assessing Low Back Pain

    Jan 1, 2013, 00:00

  • Sustaining Universal Health Coverage- The Interaction of Social, Political, and Economic Sustainability

    Jan 1, 2013, 00:00

  • Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine- Results from the American Migraine Prevalence and Prevention (AMPP) Study

    Jan 1, 2013, 00:00

  • Editorial Board

    Jan 1, 2013, 00:00

  • Reviewer Acknowledgment

    Jan 1, 2013, 00:00

  • Transparent Interactive Decision Interrogator—Reply to Letter to the Editor by Michael Coory

    Jan 1, 2013, 00:00

  • Table of Contents

    Jan 1, 2013, 00:00

  • Multidomain Patient-Reported Outcomes of Irritable Bowel Syndrome- Exploring Person-Centered Perspectives to Better Understand Symptom Severity Scores

    Jan 1, 2013, 00:00

  • The Importance of Values in Shaping How Health Systems Governance and Management Can Support Universal Health Coverage

    Jan 1, 2013, 00:00

  • Turning the Spotlight on Experimental Design in Discrete Choice Experiments—A Focus on Pragmatic Approaches in Health

    Jan 1, 2013, 00:00

  • Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

    Jan 1, 2013, 00:00

  • Instructions for Authors

    Jan 1, 2013, 00:00

  • Which Health-Related Quality-of-Life Outcome When Planning Randomized Trials- Disease-Specific or Generic, or Both? A Common Factor Model

    Jan 1, 2013, 00:00

  • TIDI Addresses Uncertainty But Not Indeterminism

    Jan 1, 2013, 00:00

  • Economic Efficiency of Countries’ Clinical Review Processes and Competitiveness on the Market of Human Experimentation

    Jan 1, 2013, 00:00

  • Instructions for Authors

    Jan 1, 2013, 00:00

  • Universal Health Coverage- A Quest for All Countries But under Threat in Some

    Jan 1, 2013, 00:00

  • Assessing the Added Value of Health Technologies- Reconciling Different Perspectives

    Jan 1, 2013, 00:00

  • Assessing the Impact of Privatizing Public Hospitals in Three American States- Implications for Universal Health Coverage

    Jan 1, 2013, 00:00

  • Core Domains for a Person-Focused Outcome Measurement System in Cancer (PROMS-Cancer Core) for Routine Care- A Scoping Review and Canadian Delphi Consensus

    Jan 1, 2013, 00:00

  • Is Management Essential to Improving the Performance and Sustainability of Health Care Systems and Organizations? A Systematic Review and a Roadmap for Future Studies

    Jan 1, 2013, 00:00

  • Copyright/Subscription

    Jan 1, 2013, 00:00

  • Editorial Board

    Jan 1, 2013, 00:00

  • Understanding the Impact of Global Trade Liberalization on Health Systems Pursuing Universal Health Coverage

    Jan 1, 2013, 00:00

  • Using Resource Use Logs to Reduce the Amount of Missing Data in Economic Evaluations Alongside Trials

    Jan 1, 2013, 00:00

  • The Effects of Diabetes, Hypertension, Asthma, Heart Disease, and Stroke on Quality-Adjusted Life Expectancy

    Jan 1, 2013, 00:00

  • A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework

    Jan 1, 2013, 00:00

  • Detecting Changes in Patient Treatment Satisfaction with Medicines- The SATMED-Q

    Jan 1, 2013, 00:00

  • Setting the Scene- The Challenges of Universal Health Coverage and the Contribution of Management Education

    Jan 1, 2013, 00:00

  • Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program

    Jan 1, 2013, 00:00

  • Binary Choice Health State Valuation and Mode of Administration- Head-to-Head Comparison of Online and CAPI

    Jan 1, 2013, 00:00

  • Rejoinder to Commentary- When Mapping Treatment Effects from Disease-Specific to Generic Scales, Ordinary Least Squares Regression Underestimates the Benefits of Treatment

    Jan 1, 2013, 00:00

  • Adding Decision Models to Systematic Reviews- Informing a Framework for Deciding When and How to Do So

    Jan 1, 2013, 00:00

  • Some Comments on Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales

    Jan 1, 2013, 00:00

  • An International Survey of the Public Engagement Practices of Health Technology Assessment Organizations

    Jan 1, 2013, 00:00

  • Constructing Experimental Designs for Discrete-Choice Experiments- Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force

    Jan 1, 2013, 00:00

  • Code of Ethics

    Jan 1, 2013, 00:00

  • The International Society for Pharmacoeconomics and Outcomes Research

    Jan 1, 2013, 00:00

  • The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer- A Health Economic Decision Analysis

    Jan 1, 2013, 00:00

  • Universal Health Coverage—Big Thinking versus Big Data

    Jan 1, 2013, 00:00

  • Cost-Effectiveness of Interventions for Reducing Road Traffic Injuries Related to Driving under the Influence of Alcohol

    Jan 1, 2013, 00:00

  • ERRATUM

    Jan 1, 2013, 00:00

  • Identifying Differential Responders and Their Characteristics in Clinical Trials- Innovative Methods for Analyzing Longitudinal Data

    Jan 1, 2013, 00:00

  • Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales- A Common Factor Model

    Jan 1, 2013, 00:00

  • Cost-Effectiveness Analysis- Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists

    Jan 1, 2013, 00:00

  • Cost-Effectiveness of Gene-Expression Profiling for Tumor-Site Origin

    Jan 1, 2013, 00:00

  • Copyright/Subscription

    Jan 1, 2013, 00:00

  • Whole Disease Modeling to Inform Resource Allocation Decisions in Cancer- A Methodological Framework

    Dec 1, 2012, 00:00

  • The Use of Qualitative Methods in Developing the Descriptive Systems of Preference-Based Measures of Health-Related Quality of Life for Use in Economic Evaluation

    Dec 1, 2012, 00:00

  • Measuring and Valuing Health Benefits for Economic Evaluation in Adolescence- An Assessment of the Practicality and Validity of the Child Health Utility 9D in the Australian Adolescent Population

    Dec 1, 2012, 00:00

  • Preferences for Managing Symptoms of Differing Severity- A Discrete Choice Experiment

    Dec 1, 2012, 00:00

  • What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward

    Dec 1, 2012, 00:00

  • Demonstrating the Burden of Hypoglycemia on Patients' Quality of Life in Diabetes Clinical Trials- Measurement Considerations for Hypoglycemia

    Dec 1, 2012, 00:00

  • Table of Contents

    Dec 1, 2012, 00:00

  • Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values- Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D

    Dec 1, 2012, 00:00

  • Comparisons of Food and Drug Administration and European Medicines Agency Risk Management Implementation for Recent Pharmaceutical Approvals- Report of the International Society for Pharmacoeconomics and Outcomes Research Risk Benefit Manag ...

    Dec 1, 2012, 00:00

  • Work Productivity in Relapsing Multiple Sclerosis- Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life

    Dec 1, 2012, 00:00

  • Cost-Effectiveness of Using a Molecular Diagnostic Test to Improve Preoperative Diagnosis of Thyroid Cancer

    Dec 1, 2012, 00:00

  • Multiple Criteria Decision Analysis for Health Technology Assessment

    Dec 1, 2012, 00:00

  • Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research- A Report of the ISPOR Personalized Medicine Special Interest Group

    Dec 1, 2012, 00:00

  • The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

    Dec 1, 2012, 00:00

  • Comparing 15D and SF-6D Performance in Fragility Wrist and Hip Fracture Patients in a Two-Year Follow-Up Case-Control Study

    Dec 1, 2012, 00:00

  • Inquiry into the Relationship between Equity Weights and the Value of the QALY

    Dec 1, 2012, 00:00

  • Budget Impact Analysis of HIV Testing in the VA Healthcare System

    Dec 1, 2012, 00:00

  • Instructions for Authors

    Dec 1, 2012, 00:00

  • Patient-Level Hospital Costs and Length of Stay After Conventional Versus Minimally Invasive Total Hip Replacement- A Propensity-Matched Analysis

    Dec 1, 2012, 00:00

  • Unidimensional 12-Item Zarit Caregiver Burden Interview for the Assessment of Dementia Caregivers’ Burden Obtained by Item Response Theory

    Dec 1, 2012, 00:00

  • Measuring Health-Related Quality of Life in Leukemia- The Functional Assessment of Cancer Therapy – Leukemia (FACT-Leu) Questionnaire

    Dec 1, 2012, 00:00

  • Contingent Valuation Scenarios for Chronic Illnesses- The Case of Childhood Asthma

    Dec 1, 2012, 00:00

  • Editorial Board

    Dec 1, 2012, 00:00

  • What Is Wrong with Orphan Drug Policies?

    Dec 1, 2012, 00:00

  • Development of the Shortness of Breath with Daily Activities Questionnaire (SOBDA)

    Dec 1, 2012, 00:00

  • A Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients with T3, Stage II Colon Cancer- Impact on Quality-Adjusted Life Expectancy and Costs

    Dec 1, 2012, 00:00

  • Copyright/Subscription

    Dec 1, 2012, 00:00

  • Rank Reversal in Indirect Comparisons

    Dec 1, 2012, 00:00

  • Comparison of Generic, Condition-Specific, and Mapped Health State Utility Values for Multiple Myeloma Cancer

    Dec 1, 2012, 00:00

  • PDB35 Evaluation of the Long Term Economic Impact of Improving Hba1C in Type 2 Diabetes Patients in Saudi Arabia

    Nov 1, 2012, 00:00

  • HT3 Development of a Check List for Quality Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Taiwan

    Nov 1, 2012, 00:00

  • ISPOR 5th Asia-Pacific Conference Disclosure Information for Research Presentations

    Nov 1, 2012, 00:00

  • PHP63 Integrated Medication Reconciliation Model in Computerized Physician Order Entry (CPOE) System

    Nov 1, 2012, 00:00

  • PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada

    Nov 1, 2012, 00:00

  • Ex2 An Observation on the Trend of Outpatient Clinic Utilization and Numbers of Medical Prescription Given in Taiwan Elderly Between 1997 and 2010

    Nov 1, 2012, 00:00

  • PMH11 The Cost-Effectiveness of Risperidone Long-Acting Injection in Schizophrenia Treatment- A Systematic Review

    Nov 1, 2012, 00:00

  • PSS30 Cosmeceutiqol- A Dermo-Cosmetic Quality-of-Life Assessment Tool

    Nov 1, 2012, 00:00

  • PIN11 Pharmacotherapy of Acute Bronchitis in Clinics- Results of Pharmacoepidemical Research

    Nov 1, 2012, 00:00

  • PRM40 Applying Stratification on Time to Overcome Time-Varying Covariates Effects in Cox Proportional Hazards Models

    Nov 1, 2012, 00:00

  • PMS77 Real-World Comparison of Health Care Utilization Between Duloxetine Initiators and Pregabalin Initiators Among Fibromyalgia Patients

    Nov 1, 2012, 00:00

  • PND49 The Measurement of Quality of Life in Children With Cystic Fibrosis With Using Russian Version of Health Utility Index (HUI) Questionnaire

    Nov 1, 2012, 00:00

  • PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma

    Nov 1, 2012, 00:00

  • PSS35 Frequency of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration- Canadian Real-World Utilization Data

    Nov 1, 2012, 00:00

  • PRS31 Cost-Effectiveness of an Intensive Intervention Program in the Control of Allergic Rhinitis Due to Ragweed Pollen in Quebec, Canada

    Nov 1, 2012, 00:00

  • PCN80 Modelling the Cost-Effectiveness of Ipilimumab for Previously-Treated, Metastatic Melanoma

    Nov 1, 2012, 00:00

  • PMH36 Time Trade-Off (TTO) Analysis to Elicit Health State Utilities Related to Long Acting Treatments in Schizophrenia

    Nov 1, 2012, 00:00

  • PHP77 Pharmaceutical Benefit Advisory Committee Acceptability Threshold Results 2005-2011

    Nov 1, 2012, 00:00

  • PHP38 Persistent Racial and Ethnic Disparities in Health Care Utilization – Evidence from National Health Interview Survey

    Nov 1, 2012, 00:00

  • PMH39 Identifying Disease-Defining Concepts Using Spontaneous and Probed Responses From Semi-Structured Qualitative Interviews in Patients With Major Depressive Disorder

    Nov 1, 2012, 00:00

  • PRM9 Using Propensity Score Matching to Estimate the Resource Burden of Hospital Acquired Clostridium Difficile Infection in England

    Nov 1, 2012, 00:00

  • PHP24 Should Pharmacist Remuneration Systems in Europe Be Reformed in Order to Increase Generic Medicine Dispensing?

    Nov 1, 2012, 00:00

  • PCV69 Economic Evaluation of Thrombo Incode, a Genetic Platform for the Assessment of Venous Thromboembolism (VTE) Risk in Patients With a Pattern of VTE or a Condition That Suggests a Hereditary Component

    Nov 1, 2012, 00:00

  • PIH13 The Costs of Unintended Pregnancy in Russia

    Nov 1, 2012, 00:00

  • PCN154 Are Population-Based Registries a Suitable Tool for Outcomes Research in Cancer? Experiences from Four Registries

    Nov 1, 2012, 00:00

  • PCN110 Differences in Health-Related Quality of Life Between Children Treated for Acute Lymphoblastic Leukemia (ALL) on Dana Farber Cancer Institute (DFCI) Protocols

    Nov 1, 2012, 00:00

  • PMS41 Cost-Effectiveness of Denosumab in Preventing Osteoporotic Fractures in Postmenopausal Women from the Private Health Care Setting Perspective in Brazil

    Nov 1, 2012, 00:00

  • PMH32 Modelling the Cost and Effectiveness Outcomes Associated With Different Sequences for the Treatment of Chronic Schizophrenia- An Economic Evaluation of Paliperidone Palmitate

    Nov 1, 2012, 00:00

  • PHP20 Analysis of How Payers Incorporate Health Economic Analyses Into Coverage and HTA Decisions for Personalized Medicine Diagnostics

    Nov 1, 2012, 00:00

  • PMH38 Assessing Depressive Symptoms in Primary Care- Psychometrical Properties of the Spanish Version of the Clinically Useful Depression Outcome Scale

    Nov 1, 2012, 00:00

  • NI4 Analysis of Stakeholders Involved in HTA Decision Making Process in the UK

    Nov 1, 2012, 00:00

  • PHS55 Inequalities and Avoidable Costs of Imaging Test in the Diagnosis and Monitoring of Patients With Stroke in the Canary Islands

    Nov 1, 2012, 00:00

  • HT4 Health Technology Assessment Map in Asia – Regional Versus International Influences

    Nov 1, 2012, 00:00

  • PMD86 Inappropriate Use of Upper Gastrointestinal Endoscopy in Clinical Practices in Japan

    Nov 1, 2012, 00:00

  • CV1 Statin Prescription in Australia- A Comparison of Differences in Prescribed Doses and Potential Impact on Health Outcomes

    Nov 1, 2012, 00:00

  • PCN23 Cancer Related Bisphosphonate Therapy in Different Treatment Facilities

    Nov 1, 2012, 00:00

  • PMS7 The Medication Costs of Rheumatoid Arthritis - Comparing Before and After Introduction of the Biologics

    Nov 1, 2012, 00:00

  • PRM152 Is it Just Semantics? The Use of “Efficacy” and “Effectiveness” in Comparative Effectiveness Reviews and Health Technology Assessments

    Nov 1, 2012, 00:00

  • PIH25 Testosterone Replacement Therapy in Males with Hypogonadism in Sweden- A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PCV33 Self-Reported Health Status Among Taiwanese Hypertensive Elderly

    Nov 1, 2012, 00:00

  • PSY2 Effect of Intravenous Parecoxib on Postoperative Pain Relief After Total Knee Arthroplasty

    Nov 1, 2012, 00:00

  • PHP189 Trends in the Use of Innovative Contracting Models Between the Pharmaceutical Industry and Payers in Europe

    Nov 1, 2012, 00:00

  • PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”)- A Structured Survey Analysis One Year After Enactment

    Nov 1, 2012, 00:00

  • PDB36 An Evaluation of the Long-Term Costs and Effects of a 1% Reduction in HbA1C in Type 2 Diabetes Patients in Malaysia

    Nov 1, 2012, 00:00

  • PCN15 Clinical and Cost-Effectiveness of Proton Beam Radiotherapy for Eye Cancer- A Systematic Review

    Nov 1, 2012, 00:00

  • PHP165 Exploring the Role of the Committee in the Nice Appraisal Process- How Consistent are Decisions Across Committees?

    Nov 1, 2012, 00:00

  • PRS17 Availability, Affordability and Price of Asthma Medicines in Tehran; Iran

    Nov 1, 2012, 00:00

  • PMS68 The Use of Monitoring Systems to Better Regulate Drug Consumption in Hungarian Hospitals

    Nov 1, 2012, 00:00

  • PRS38 Turkish Cultural Adaptation and Validation of Smoking Cessation Quality of Life (SCQoL) Questionnaire

    Nov 1, 2012, 00:00

  • PHP133 Market Access of Drugs in France and Medico-Economic Assessment

    Nov 1, 2012, 00:00

  • PCN96 Cost Minimization Analysis of Xeloda® Versus 5-Fluorouracil-Based Treatment for Gastric Cancer Patients in Hong Kong

    Nov 1, 2012, 00:00

  • PR1 Comparison of Cancer Drug Prices in the United States and the Uk

    Nov 1, 2012, 00:00

  • PHP42 Do Macroeconomic Conditions Explain Drug Price Variations Across Countries? A Cross-Sectional Analysis

    Nov 1, 2012, 00:00

  • PHP33 Drug-Related Problems and Length of Stay in the Management of Infection in Patients with Chronic Kidney Disease

    Nov 1, 2012, 00:00

  • PRM5 Attribution of Benefit to the Three Disease Dimensions Mortality, Morbidity, Quality of Life Within Early Benefit Assessment (EBA) in Germany

    Nov 1, 2012, 00:00

  • PSY20 Cost-Effectiveness of Prophylaxis With an Anti-Inhibitor Complex Concentrate in Patients With Haemophilia and Inhibitors- Results From Pro-Feiba Study

    Nov 1, 2012, 00:00

  • PRM157 Methodological Challenges of IQWiG's Efficiency Frontier Concept Elicited by Multiple Patient-Relevant Endpoints – Why Prioritization of Endpoints Cannot Be Avoided

    Nov 1, 2012, 00:00

  • PMS13 Cost-Effectiveness of Biological Treatments in Patients with Rheumatoid Arthritis in Taiwan

    Nov 1, 2012, 00:00

  • PMS30 Pharmacoeconomic Evaluation of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Reducing Disease Activity in Patients With Rheumatoid Arthritis

    Nov 1, 2012, 00:00

  • PRM35 Prevalence of Rare Diseases – A Special Challenge for Benefit Assessment and Health Economics

    Nov 1, 2012, 00:00

  • PSU24 The Equivalence of Remote Electronic and Paper Collection of Patient Reported Outcomes (PROS)- A Crossover Trial

    Nov 1, 2012, 00:00

  • PSU12 Minimally Invasive Surgery in Spinal Fusion - Clinical and Economical Impact From Hospital Perspective

    Nov 1, 2012, 00:00

  • PDB66 Quantifying the Impact of Poor Glycaemic Control Compared With Guidelines in the Treatment of Type 2 Diabetes in UK Clinical Practice

    Nov 1, 2012, 00:00

  • CN4 Inpatient Treatment Patterns and Health Care Expenditures for Hepatocellular Carcinoma Among Population With Urban Basic Health Insurance in China

    Nov 1, 2012, 00:00

  • PMH14 Resilience Resources Predict Higher Quality of Life (QOL) Among Taiwanese Dialysis Patients

    Nov 1, 2012, 00:00

  • PRS28 Cost-Effectiveness Analysis of Montelukast in 6-14-Year-Old Children With Mild-Moderate Persistent Asthma in Belarus

    Nov 1, 2012, 00:00

  • PDB45 Cost-Effectiveness of Vildagliptin Compared to Generic Sulphonylureas Added on to Metformin From the Portuguese Societal Perspective

    Nov 1, 2012, 00:00

  • PCN38 Impact of Biomarker Testing on Clinical and Economic Outcomes in Advanced Cancer Treatment

    Nov 1, 2012, 00:00

  • PCN59 Patterns of Clinical Management and Resource Utilization for Postmenopausal Hormone Receptor–Positive HER2-Negative (HR+ HER2–) Advanced Breast Cancer (ABC) in Europe

    Nov 1, 2012, 00:00

  • PCN124 Lost Productivity in Population of Cancer Patient's Close Relatives in Poland

    Nov 1, 2012, 00:00

  • PCN2 The Relationship of Following Lipid-Lowering Drugs Used With Adjuvant Hormonal Therapy in Breast Cancer Women

    Nov 1, 2012, 00:00

  • PDB21 Chart Audit and Budget Impact Analysis of Pasireotide Versus Second-Line Therapies in the Treatment of Cushing's Disease in Germany

    Nov 1, 2012, 00:00

  • PHP102 Patient Satisfaction with Pharmacies Condition

    Nov 1, 2012, 00:00

  • PHP62 A Novel Global Health Drug Subsidy AMFm- Assessment of Deployment in Southern Ghana

    Nov 1, 2012, 00:00

  • PRM27 Feasibility, Comparability, and Reliability of the Standard Gamble Compared With the Rating Scale and Time Trade-Off Techniques in the EQ-5D-5L Valuation Study

    Nov 1, 2012, 00:00

  • PMS14 Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis in China

    Nov 1, 2012, 00:00

  • PRS25 Cost Analysis of Omalizumab Use in Patients With Severe Uncontrolled Asthma Within the Mexican Public Health Care System

    Nov 1, 2012, 00:00

  • PCN139 Characteristics of Long-Acting Somatostatin (SSA) Use in Gastro-Entero-Pancreatic Neuroendocrine (GEP-NET) Tumors in the Netherlands

    Nov 1, 2012, 00:00

  • PIH29 Identification of Factors and Their Influence on Patient Adherence to Intravenous Medication for Chronic Conditions- Findings of a Literature Review in Osteoporosis and Crohn's Disease

    Nov 1, 2012, 00:00

  • PRM121 Burden of Osteoarthritis- Development of a Questionnaire

    Nov 1, 2012, 00:00

  • PRM14 European Assessment of the Validity of the QALY Outcome Measure- Results From the Experiment Conducted by the Echoutcome Project

    Nov 1, 2012, 00:00

  • PDB73 Obesity and Frequent Hypoglycemia in European Type 2 Diabetes Patients

    Nov 1, 2012, 00:00

  • PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK- A Cost-Utility Analysis

    Nov 1, 2012, 00:00

  • PIN25 Health and Economic Benefits of Avoiding Hospital Pen Moves for Dairy Cattle in the United States

    Nov 1, 2012, 00:00

  • PHS20 Cost Associated to the Management of Inappropriate Shocks in Patients With an Implantable Cardioverter Defibrillator – Cardina Study

    Nov 1, 2012, 00:00

  • PUK8 4-Year Incidence and Costs of Hospitalized Complications Within Kidney Transplant Patients in France

    Nov 1, 2012, 00:00

  • PMS25 Structure of Direct Cost of Care of Patients Treated for Severe Rheumatoid Arthritis in France

    Nov 1, 2012, 00:00

  • PCV96 Relationship Between Inflammation and Patient Functioning in Cardiovascular Disease- A Review of the Literature

    Nov 1, 2012, 00:00

  • PRM95 Does the Cat Questionnaire Produce Similar Results When Self- or Interviewer-Administered?

    Nov 1, 2012, 00:00

  • PRM8 Costing Issue in Pharmacoeconomic Studies from the Perspective of Singapore Public Health Care Provider

    Nov 1, 2012, 00:00

  • PND67 The Impact of Memantine and Cholinesterase Inhibitors Initiation for Alzheimer'S Disease on the Use of Antipsychotics Agents- Analysis Using the Ramq Database

    Nov 1, 2012, 00:00

  • PMS70 Utilization of Pain Medications Among Osteoarthritis Patients Who Initiated Duloxetine and Standard of Care for Pain Management

    Nov 1, 2012, 00:00

  • PDB6 Real-World Comparative Effectiveness Analysis of Patients Initiating Injectable Treatments for Type 2 Diabetes Mellitus (T2DM)- Pilot Data From the Initiator Study

    Nov 1, 2012, 00:00

  • PRM163 The Use of Expected Value of Perfect Information Analysis Within Economic Evaluations and Health Technology Assessments in the UK

    Nov 1, 2012, 00:00

  • PCV120 The Factors Which Affect the Price of Antihypertensive Combinations Including Angiotensin Receptor Blockers

    Nov 1, 2012, 00:00

  • PIN10 Epidemiology and Economic Burden of Pneumomococcal Disease in Older Adults in Taiwan

    Nov 1, 2012, 00:00

  • PIN69 Cost Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in Malaysia

    Nov 1, 2012, 00:00

  • PIN46 Pharmacoeconomic Evaluation of the Introduction of Universal Varicella Vaccination in Italy

    Nov 1, 2012, 00:00

  • PRM158 Placebo-Controlled Clinical Trials- A Difficult Balance “Justification Versus Feasibility” for Academic Sponsors

    Nov 1, 2012, 00:00

  • PRS10 Assessment of Knowledge Regarding Tuberculosis Among General Population in North East Libya

    Nov 1, 2012, 00:00

  • PHP83 Community Pharmacist'S Perceptions Towards the Quality of Locally Manufactured Generic Medicines- A Descriptive Study from Malaysia

    Nov 1, 2012, 00:00

  • RE3 How Will the New NHS Changes in England Impact the Implementation of Risk-Sharing Schemes for Oncology Treatments?

    Nov 1, 2012, 00:00

  • PRS14 Clinical and Pharmacoeconomic Aspects of Allergen Immunotherapy in the Slovak Republic

    Nov 1, 2012, 00:00

  • PMD85 Agent-Based Cardiovascular Disease Model for India

    Nov 1, 2012, 00:00

  • PHP149 Health Technology Assessment Evidence Criteria- What Types of Evidence Should Be Presented for Products Used to Screen for Disease in the United States?

    Nov 1, 2012, 00:00

  • PMD50 Cost-Effectiveness Analysis of Four Validated Techniques of Accelerated Partial Breast Irradiation for the Treatment of Early-Stage Breast Cancer- Spanish Public Health System Standard Estimations

    Nov 1, 2012, 00:00

  • PDB79 Treatment Patterns of Oral Anti-Diabetic Drugs in the UK

    Nov 1, 2012, 00:00

  • PSY8 Budget Impact Analysis of Ustekinumab for the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Thailand

    Nov 1, 2012, 00:00

  • PGI39 Budegt Impact Analysis of HCV Therapy Cost After Boceprevir Addition to Standard Therapeutic Regime

    Nov 1, 2012, 00:00

  • PHS72 Quality of Life With Type2 Diabetes- Translation and Validation of Indian Version of MDQ

    Nov 1, 2012, 00:00

  • PCV101 Japanese Patients and Physicians Preferences for Anticoagulants Use in Atrial Fibrillation - Results From a Conjoint-Analysis Study

    Nov 1, 2012, 00:00

  • PHP175 Economic Performance and Epidemiological Transition in Mexico

    Nov 1, 2012, 00:00

  • PRM67 The Use of Health Economic Models in Hungarian Health Technology Assessment

    Nov 1, 2012, 00:00

  • PMD36 Cost-Analysis of PCR Guided Pre-Emptive Antibiotic Treatment of S.aureus-infections- An Analytic Decision Model

    Nov 1, 2012, 00:00

  • PRM19 Something for Nothing? The Value of Informal Care

    Nov 1, 2012, 00:00

  • PRM160 A New Value-Based Pricing Framework for the Optimal Pricing of Pharmaceutical Assets

    Nov 1, 2012, 00:00

  • PHP97 Identifying Modeling Factors Influencing Coverage Decisions by Nice in 10 Single Technology Appraisals (STA) of Expensive Drugs

    Nov 1, 2012, 00:00

  • PHP6 The Study of Antihyperglycemic Drug Use Patterns and the Toward Clinical Excellence Network'S Diabetes (TCEN DM) Indicators in Patients with Type 2 Diabetes Mellitus at Samutsakhon Hospital

    Nov 1, 2012, 00:00

  • PHS59 Demographics and Health-State Utilities of Irish Patients With Hepatitis C Infection; Use of the 5-Level EQ-5D Questionnaire

    Nov 1, 2012, 00:00

  • PRM17 Cost-Utility Analysis of Donepezil for the Treatment of Alzheimer's Disease in Thailand

    Nov 1, 2012, 00:00

  • PHP191 Impact of a Financial Risk-Sharing Scheme on Budget-Impact Estimations- A Game-Theoretic Approach

    Nov 1, 2012, 00:00

  • PMD18 Introduction of Novel Biomarker Testing for Ovarian Cancer- Budget Impact Analysis for an Italian Regional Health Care Service

    Nov 1, 2012, 00:00

  • PCV12 Efficacy of Heart Failure Pharmacological Treatment Classes and Combinations- Network Meta-Analyses

    Nov 1, 2012, 00:00

  • PHP89 Market Access of Drugs in Fran Evolution or Revolution?

    Nov 1, 2012, 00:00

  • PRM45 Are Minimal Clinically Important Difference Measures (MCIDs) Relevant for Survival Outcomes? Introducing the MCID-CAC

    Nov 1, 2012, 00:00

  • PIN48 Cost-Efectiveness Analysis of Darunavir Versus Atazanavir, Each in Combination With Emtricitabine and Tenofovir, for the Management of Naive Anti-Retroviral HIV Infected Patients, Under the Belgian Social Security Perspective

    Nov 1, 2012, 00:00

  • PHP33 The Use of Extreme Value Statistics in Assessing Long Decision Times in Public Funding of Medicines with New Molecules or Therapeutic Indications

    Nov 1, 2012, 00:00

  • PMH52 Health Care Resource Utilization and Costs for Patients With Anorexia Nervosa, Bulimia Nervosa, and Binge Eating Disorder

    Nov 1, 2012, 00:00

  • PHP25 The Pharmaceutical Industry as Partner in Integrated Care Contracts - Potential Improvement or Vain Attempt? First Experiences from Germany

    Nov 1, 2012, 00:00

  • PHP70 A 3-Year Follow-Up Study on National Health Insurance Reimbursements Among Atrial Fibrillation Patients With/Without Stroke in Taiwan- A Population-Based Study

    Nov 1, 2012, 00:00

  • PSU33 Characteristics and Burden of Tuberous Sclerosis Complex- Results of a Patient and Caregiver Survey in the United States

    Nov 1, 2012, 00:00

  • PND41 The Cost-Effectiveness of Buccolam for the Treatment of Prolonged, Acute, Convulsive Epileptic Seizures in Spain

    Nov 1, 2012, 00:00

  • PIH15 Prescribing Cost of Enzymes Over a Two-Year Period Using a Medical Insurance Claims Database

    Nov 1, 2012, 00:00

  • PIN14 Projecting the Clinical Impact of Treating Hepatitis C Genotype 1 Infection With Boceprevir in Germany

    Nov 1, 2012, 00:00

  • PHS74 Does Disease Advocacy Impact Priority Setting- Evidence From the Needs and Priorities for Comprehensive Liver Cancer Control in 12 Countries in Europe and Asia-Pacific

    Nov 1, 2012, 00:00

  • PMH7 Analyses of Switching and Combination Use of Antidepressants in Young Swedish Adults

    Nov 1, 2012, 00:00

  • PHP124 Comparison of HTA Dossier Requirements Across Europe

    Nov 1, 2012, 00:00

  • PRM28 A Refined Comorbidity Index for the Studies of Health Related Quality of Life

    Nov 1, 2012, 00:00

  • PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment

    Nov 1, 2012, 00:00

  • PUK11 Cost-Effectivness Analysis of Once Daily Versus Twice Daily Tacrolimus in Post-Renal Transplant Patients in the Czech Republic

    Nov 1, 2012, 00:00

  • PND20 12-Month Cost of Illness Study of Moderate Alzheimer'S Disease Patients in Spain- The Evocost Study

    Nov 1, 2012, 00:00

  • PCV56 Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at LDL Cholesterol Treatment Goal in Brazil

    Nov 1, 2012, 00:00

  • PCV22 Pharmacist'S Involvement in a Multidisciplinary Ischemic Stroke Team in and its Associated Cost Avoidance

    Nov 1, 2012, 00:00

  • PIH40 What Do Health Economists Expect from Their Employer- Results from an On-Line Survey in Germany

    Nov 1, 2012, 00:00

  • PHP190 Global Pharmaceutical Risk-Sharing Agreement Trends in 2011 and 2012- Slowing Down?

    Nov 1, 2012, 00:00

  • PUK5 Employment Rates and Indirect Costs in Patients With End-Stage Renal Disease- Differences Between Modalities of Renal Replacement Therapy

    Nov 1, 2012, 00:00

  • PMS23 Total Health Care Costs Associated With Ankylosing Spondylitis Incident Cases in Turkey

    Nov 1, 2012, 00:00

  • PHP96 National Health Insurance Claims Database As a Valuable Source of Information for Health Technology Assessment in Taiwan

    Nov 1, 2012, 00:00

  • PCN146 Trends in Computed Tomography Use in Canada- Low-Dose Ionizing Radiation and the Potential Related Cancer Risk

    Nov 1, 2012, 00:00

  • PHP43 The High Cost of Treating Cancer- Do Manufacturer Pricing Policies Take Affordability Into Account?

    Nov 1, 2012, 00:00

  • PSS23 Patient Burden Associated With Lack of Treatment Satisfaction Amongst Psoriasis Patients Receiving Traditional Systemic Therapies

    Nov 1, 2012, 00:00

  • PMH6 Evolution of Antidepressant Efficacy Over Time- Illustration With Escitalopram

    Nov 1, 2012, 00:00

  • PGI1 The Effectiveness and Tolerability of Combined Treatment With Peginterferon Alpha-2a or Alpha-2b and Ribavirin in the Treatment of Patients With Chronic Hepatitis C- Results Based on the Nationwide Hepatitis Registry in Japan

    Nov 1, 2012, 00:00

  • PRM43 Roles and Selection of Comparative Treatment(s) in the Assessment of New Drug Reimbursement and Pricing Application to Taiwan National Health Insurance (NHI)

    Nov 1, 2012, 00:00

  • PDB76 Clinical Effectiveness of Increased Physical Activity in Type 2 Diabetes, Systematic Review

    Nov 1, 2012, 00:00

  • PRM92 Exploratory Mapping of the LupusQol to the SF-6D

    Nov 1, 2012, 00:00

  • PRM88 Translation and Validation of Osteoporosis Health Belief Scale Into Malaysian Version Among Type 2 Diabetics Patients

    Nov 1, 2012, 00:00

  • PRM106 Examination of Preferences Elicited From the General Public- Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PHP66 Socioeconomic Inequalities in Health in Urban Pakistan

    Nov 1, 2012, 00:00

  • PMH9 Antidepressant Prescription Patterns Among Patients With Major Depression Based on Claims Database in Japan

    Nov 1, 2012, 00:00

  • PIN35 Cost of Antimicrobial Prescribing Using a Large Pharmacy Database in South Africa

    Nov 1, 2012, 00:00

  • PHP104 Hypertension Control and Doctors' Knowledge, Attitude and Practices on Malaysian Clinical Practice Guidelines on Management of Hypertension (CPG 2008) at a Tertiary Hospital

    Nov 1, 2012, 00:00

  • PIH14 Cost of Illness in Women with Endometriosis

    Nov 1, 2012, 00:00

  • HC2 A Review of Economic Evaluations of New Drugs Priced by the Similar Drug Comparison Method in Japan- Did Cost-Effectveness Results Justify Premiums?

    Nov 1, 2012, 00:00

  • PHP83 The OTC Policy in Eyrope and Greece

    Nov 1, 2012, 00:00

  • PMD72 The Use of Multi-Criteria Decision Analysis to Elicit Colorectal Cancer Screening Preferences

    Nov 1, 2012, 00:00

  • PA2 Hospital-Based HTA in Italy- Diffusion and Potential Impact

    Nov 1, 2012, 00:00

  • PHP9 Assessment of Diagnostic Need for Magnetic Resonance Imaging in Medicare Patients with Pacemaker Implants

    Nov 1, 2012, 00:00

  • PIN76 Health Related Quality of Life of HIV Infected Intravenous Drug Users

    Nov 1, 2012, 00:00

  • PSY19 A Cost-Consequence Analysis of Patient Self-Management Versus Physician-Managed Monitoring of Long-Term Oral Anticoagulation Therapy in Canada

    Nov 1, 2012, 00:00

  • PRM104 Examination of Patient Preferen Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments

    Nov 1, 2012, 00:00

  • PHP206 Assessing the Value of Access to Individual Patient Data for Reimbursement Decisions

    Nov 1, 2012, 00:00

  • PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes - A Population Based Study

    Nov 1, 2012, 00:00

  • PCN72 Modeling the Survival Loss in Patients With Philadelphia Chromosome Positive (Ph+) Chronic Phase Chronic Myeloid Leukemia (CML-CP) Switched from Imatinib Mesylate to a Generic Copy

    Nov 1, 2012, 00:00

  • PHP50 Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

    Nov 1, 2012, 00:00

  • PCN106 Persistence in Patients With Breast Cancer Treated With Tamoxifen or Aromatase Inhibitors- Results of a Retrospective Cohort Study

    Nov 1, 2012, 00:00

  • PHP40 AMNOG- Pricing Reforms in Action

    Nov 1, 2012, 00:00

  • PIN61 The Cost-Utility of Telaprevir in Combination With Peginterfeon Alpha and Ribavirin (PR) as Compared to the Combination Boceprevir With PR and to PR Alone in the Management of Chronic Hepatitis C in the Netherlands

    Nov 1, 2012, 00:00

  • PCN117 Quality of Life in Patients With Malignant Ascites After Treatment With Catumaxomab- A Multicenter Phase II/III Study Comparing Paracentesis Plus Catumaxomab With Paracentesis Alone

    Nov 1, 2012, 00:00

  • PCV59 Where Did the Time Go?- Temporal Uncertainty in Cost-Effectiveness Decision Models

    Nov 1, 2012, 00:00

  • PIH31 Intentional and Unintentional Non-Adherence Differ Across Prevalent Conditions in a Russian Patient Population

    Nov 1, 2012, 00:00

  • PSY14 Cost- Effectiveness Analysis of Pregabalin in the Treatment of Fibromyalgia

    Nov 1, 2012, 00:00

  • PIN80 Multivariate Cox Analysis Regarding Treatment Switch on Chronic Hepatitis B (CHB) Disease Management Based on a 2-Year Prospective Study in 5 European (EU) Countries

    Nov 1, 2012, 00:00

  • PND53 Patient Reported Sleep Problems in the UK

    Nov 1, 2012, 00:00

  • PHS57 Comparing Predictors of Self-Reported Adherence to Mammography Screening Guidelines in Appalachian Women Who Utilize Mobile and Stationary Facilities

    Nov 1, 2012, 00:00

  • PCN125 Cost of Presenteeism Due to Cancer in Poland

    Nov 1, 2012, 00:00

  • PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis

    Nov 1, 2012, 00:00

  • PRM154 Source Data Verification – A Survey of Current Practice

    Nov 1, 2012, 00:00

  • PSY16 Effect of the Anti-Tumor Necrosis Factor Adalimumab on Work Productivity in Patients With Chronic Immune-Mediated Inflammatory Diseases- Literature Review

    Nov 1, 2012, 00:00

  • PHP159 Proposed and Actual Bureaucratic Burden of HTA Submissions to the Industry- Case Studies from Germany and UK

    Nov 1, 2012, 00:00

  • PHP57 Emerging Drug Reimbursement Models- Lessons and Implications from Cancer Drug Access Schemes

    Nov 1, 2012, 00:00

  • PCN11 The Impact of Treatment Persistence With Lenalidomide (LEN) for the Treatment of Multiple Myeloma (MM) on Disease Control

    Nov 1, 2012, 00:00

  • PHP56 Horizontal Equity in Primary Health Care Services in Times of Economic Crisis in Gree Ex Ante and Ex Post Findings

    Nov 1, 2012, 00:00

  • PMS62 Nominal Group Technique to Select Attributes for Discrete Choice Experiments

    Nov 1, 2012, 00:00

  • PDB44 Long-Term Evaluation of the Economic Impact of Reducing HbA1C by 1% in Type 2 Diabetes Patients in Mexico

    Nov 1, 2012, 00:00

  • PIN63 Vaccination Against Herpes Zoster and Post-Herpetic Neuralgia in Fran A Cost-Effectiveness Analysis

    Nov 1, 2012, 00:00

  • PRM63 Long-Term Burden of Asthma in Children With Allergic Rhinitis/ Conjunctivitis

    Nov 1, 2012, 00:00

  • PRM164 Ensuring the Value of a Medical Device Innovation Prior to Market Launch

    Nov 1, 2012, 00:00

  • PRM109 Content Validity of a Treatment Satisfaction Questionnaire in Non-Hodgkin's Lymphoma

    Nov 1, 2012, 00:00

  • PCN100 Cost Utility Analysis of Bortezomib in a Biomarker Positive Subgroup of Relapsed and Refractory Folicular Lymphoma

    Nov 1, 2012, 00:00

  • PMH57 HTA Landscape of Treatments Available for Alcohol-Related Disorders

    Nov 1, 2012, 00:00

  • PHP86 Outcomes and Factors Associated with Hospital Mortality in Patients with Impaired Left Ventricular Function Undergoing Coronary Bypass Grafting; Where Do We Stand?

    Nov 1, 2012, 00:00

  • PRM33 Real World Eviden Promise and Pitfalls of Real World Data

    Nov 1, 2012, 00:00

  • PCN47 Cost-of-Illness of Common Cancer Types - Results of a Health Insurance Claims Data Analysis

    Nov 1, 2012, 00:00

  • PMH12 Medication Adherence, Diabetic Care and Risk of Acute Complications of Type II Diabetics with Schizophrenia Receiving Oral Hypoglycemic Therapy

    Nov 1, 2012, 00:00

  • PMS48 Tocilizumab in Methotrexate-Intolerant or Contraindicated Patients – A Cost-Utility Model for the UK

    Nov 1, 2012, 00:00

  • PDB8 Weight Loss of ≥3% of Body Weight After Initiating New Anti-Diabetic Therapy is Associated With Glycemic Control at 6 Months in Patients With Type 2 Diabetes

    Nov 1, 2012, 00:00

  • PSS21 Evaluation of Health Utility in Patients With Retinal Vein Occlusion

    Nov 1, 2012, 00:00

  • PIN6 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C Treatment

    Nov 1, 2012, 00:00

  • PHS52 Estimating the Resources Needed to Implement a Population-Based Colorectal Cancer Screening Program Through Discrete Event Simulation

    Nov 1, 2012, 00:00

  • PUK24 Pharmacoeconomic Aspects of Use of Erythropoietin Drugs in Patients on Hemodialysis in Ukraine

    Nov 1, 2012, 00:00

  • PCN44 Cost Comparison Analysis of Antibody Therapies in the Metastatic Colorectal Carcinoma

    Nov 1, 2012, 00:00

  • PDB68 Physician Beliefs About Insulin Pens Versus Vials, Therapy Choice Factors, and Patient Characteristics Among Elderly Type 2 Diabetes Patients

    Nov 1, 2012, 00:00

  • PHP46 Burden of Herpes Zoster in Population with Compromised Immune System in South Korea

    Nov 1, 2012, 00:00

  • PGI5 Effectiveness and Safety of Antacids in Pregnant Women Suffering From Gerd/Hyperacidity Symptoms

    Nov 1, 2012, 00:00

  • PRS12 Clinical COPD Questionnaire (CCQ)- Is There a Need to Develop a Specific English Version for the Philippines and India?

    Nov 1, 2012, 00:00

  • PHP158 Cross-Funtional Challenges in the Preparation of a Benefit Dossier

    Nov 1, 2012, 00:00

  • PHP79 Stakeholders's Views Regarding the Impact of Financial Crisis on the Pharmaceutical Market in Greece

    Nov 1, 2012, 00:00

  • PDB62 Type 2 Diabetes in Russia- Prevalence, Risk Factors, and Burden

    Nov 1, 2012, 00:00

  • PCN95 Pharmacoeconomic Analysis of Direct Medical Costs Associated With the Treatment of Advanced Esophago-Gastric Cancer Therapy With Xeloda or 5-Fluorouracil (5-FU) Regimens- Implications for Health Care Utilisation in Australia

    Nov 1, 2012, 00:00

  • PHP169 Comparing the Hungarian Methodological Guideline for Conducting Economic Evaluation of Health Care Intervention with European Guidelines

    Nov 1, 2012, 00:00

  • PHP134 Biosimilar Pricing- Past, Present and Future

    Nov 1, 2012, 00:00

  • PCN5 Impact of Erythropoiesis Stimulating Agents on Survival among Patinets With Colorectal Cancer Receiving Chemotherapy

    Nov 1, 2012, 00:00

  • PCN13 Analysis of the Impact of Prophylactic Vaccination Against Human Papillomavirus Infection Using a Dynamic-Modelling Approach

    Nov 1, 2012, 00:00

  • PRM144 Cardiologists' Knowledge and Awareness of Guidelines for Medical Device Safety and Product Risk Management

    Nov 1, 2012, 00:00

  • PHS68 An Assessment of Impairment of Productivity Among SLE Patients

    Nov 1, 2012, 00:00

  • PSS31 Prevalence of Chronic Wounds in Germany — a Secondary Data Analysis

    Nov 1, 2012, 00:00

  • PRS41 Characteristics and Determinants of Palivizumab Use in the Netherlands

    Nov 1, 2012, 00:00

  • PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and at-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or no Vaccination (NoV ...

    Nov 1, 2012, 00:00

  • PIN79 Hepatitis C Virus Infection Increases the Risk of Alzheimer'S Diseases

    Nov 1, 2012, 00:00

  • PHP146 Pharmacoeconomic Education for Pharmacy Students in the Russian Federation

    Nov 1, 2012, 00:00

  • PCV12 Determinants of Exposure to Potential Interactions Between Antiplatelet Drugs, Anticoagulants, Digoxin and Common Chinese Medications in Taiwan

    Nov 1, 2012, 00:00

  • PIH4 Immunization Status and Families' Factors in Iraq

    Nov 1, 2012, 00:00

  • PHP40 Equity in Pharmaceutical Pricing and Reimbursement- Crossing the Income Divide in Asia Pacific

    Nov 1, 2012, 00:00

  • PHP78 System-Wide Impact of Payment Schemes for Integrated Care of Chronic Diseases in Europe- Evidence from an Empirical Analysis

    Nov 1, 2012, 00:00
  • «
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117 (current)
  • 118
  • 119
  • 120
  • »